NeuroMetrix, Inc. (NURO) analyst actions
Rating and price-target actions on NURO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the NURO overview →
1 measured NURO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| NeuroMetrix Reiterates its Review of Strategic Alternatives | Press release | +8.27% | +7.89% |
Keep exploring
More NURO: earnings → · SEC filings → · NURO overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| ImmuCell Corporation (ICCC) | 159 | 0.00% | 42% |
| CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN) | 158 | -1.25% | 25% |
| Leap Therapeutics, Inc. (LPTX) | 156 | -0.69% | 43% |
| GOLD FINDER RES LTD (GLDFF) | 155 | +0.19% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.